首页> 外文期刊>Clinical and Translational Gastroenterology >Rome III, Rome IV, and Potential Asia Symptom Criteria for Functional Dyspepsia Do Not Reliably Distinguish Functional From Organic Disease
【24h】

Rome III, Rome IV, and Potential Asia Symptom Criteria for Functional Dyspepsia Do Not Reliably Distinguish Functional From Organic Disease

机译:罗马III,罗马IV和潜在的亚洲功能性消化不良症状标准并不可靠地区分有机疾病的功能

获取原文

摘要

INTRODUCTION: Although the Rome criteria were created primarily for research purposes, it was an important question whether the Rome criteria can distinguish organic dyspepsia from functional dyspepsia (FD). We evaluated the accuracy of the Rome IV criteria in identifying patients with FD and compared the differences between the Rome IV, Rome III, and potential Asia criteria in identifying patients with FD. METHODS: In this cross-sectional study, we analyzed data from patients who met the inclusion and exclusion criteria from March 2018 to January 2019 at 2 tertiary hospitals. RESULTS: A total of 600 patients were enrolled in this study, including 381 individuals met the Rome IV criteria for FD, 438 individuals met the Rome III criteria for FD, and 525 individuals met the potential Asia criteria for FD. The Rome IV criteria identified patients with FD with 67.3% sensitivity and 38.4% specificity, and the positive and negative likelihood ratios of FD identified by Rome IV criteria were 1.09 (95% confidence interval 0.97–1.24) and 0.85 (95% confidence interval 0.67–1.08), respectively. There was no significant difference in the area under Rome IV, Rome III, or potential Asia criteria receiver operating characteristic curves in identifying FD ( P & 0.05). DISCUSSION: The Rome IV criteria were no better than the Rome III or potential Asia criteria in identifying FD and were not helpful in identifying patients with FD. Hence, although the Rome criteria remain useful for defining patients with FD for inclusion into clinical treatment trials, they should not be used for diagnosing FD.
机译:介绍:虽然罗马标准主要用于研究目的,但罗马标准是否可以将有机消化不良(FD)区分开来是一个重要问题。我们评估了罗马IV标准在识别FD患者方面的准确性,并比较了罗马IV,罗马III和潜在亚洲标准鉴定FD患者的差异。方法:在这种横断面研究中,我们分析了从2018年3月至2019年1月在2高级医院达到纳入和排除标准的患者的数据。结果:共有600名患者注册了这项研究,其中381名个人达到了罗马IV标准的FD,438人达到了FD的罗马III标准,525人达到了FD的潜在亚洲标准。罗马IV标准鉴定了具有67.3%敏感性和38.4%特异性的FD患者,罗马IV标准鉴定的FD的正和负似然比为1.09(95%置信区间0.97-1.24)和0.85(95%置信区间0.67分别为-1.08)。罗马IV,罗马III的面积没有显着差异,或潜在的亚洲标准接收器在识别FD(P> 0.05)中的操作特征曲线。讨论:罗马IV标准与罗马III或潜在亚洲标准识别FD的潜在标准并没有帮助识别FD患者。因此,尽管罗马标准仍然有助于定义FD含有含有临床治疗试验的患者,但它们不应用于诊断FD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号